We use cookies to ensure that we give you the best experience on our website. If you continue, we\'ll assume that you are happy to receive all cookies from this website. +Info OK

Thousands of our customers use AndroBath FX45 daily. Their feedback and our experience are signs of the effectiveness of the reason why AndroBath was developed.

Increasing the size of your penis
Learn more >>

Penis enlargement improves your self-esteem and it allows you to respond to your partner's expectations...

Increasing the size of your penis
Learn more >>

Try it, use it and if you don't get satisfactory results, return it to us and have your money back.

To access this site you must be over 18 years.
The contents of this site and the device were not submitted to the Ministry of Health. This site is not meant to prevent, diagnose, treat or cure any disease

#

Shipments are made in neutral packages without images or writings that could suggest the contents of it. The shipping documents are discreet as well.

We store our customers’ data in an off-line database for the legal time period allowed to store accounting records. We will not send you any newsletters or adverts.

Erectile dysfunction (ED) is a sexual dysfunction characterized by the inability to develop or maintain an erection that represents a satisfactory sexual performance...

Peyronie's Disease (also known as "Induratio penis plastica") is a connective tissue disorder...

MEDICAL AND
SCIENTIFIC HIGHLIGHTS
ERECTILE
DYSFUNCTION
PEYRONIE'S
DISEASE

MEDICAL AND SCIENTIFIC HIGHLIGHTS

Male anatomy

The penis is made up of two corpora cavernosa near the back and a single corpus spongiosum below. These columns are covered by a fibrous envelope called tunica albuginea. The fibers of the tunica albuginea unites to form a perforated septum which allows these corpora to work as a single unit. The corpora cavernosa and the corpus spongiosum of the penis are enclosed within the Buck's fascia, the deep connective tissue of the penis.#The spongiform cavernous tissue forms a net of interconnected spaces. These formations are made of a sponge-like tissue containing irregular blood-filled spaces lined by endothelium and separated by connective tissue septa or trabeculae. The trabeculae are fibrous bands formed partly of non-striated muscular fibers and partly of extracellular substances (elastin, collagen and fibroblasts). The penis is particularly vascularized in the internal pudendal artery, which gives off the perineal artery and the penile artery. The penile artery is divided into bulbar, urethral, spongiosum dorsal and cavernous arteries. The cavernous artery flows through the cavernous corpora and along the penis where it gives off many helicine arteries. Some of these arteries end in a capillary net-work, the branches of which open directly into the cavernous spaces. Blood passes through three kinds of veins, i.e. superficial, median and deep veins. Deep veins bring blood coming from the corpora cavernosa and the corpus spongiosum.

In some circumstances, release of nitric oxide precedes relaxation of muscles in the corpora cavernosa and corpus spongiosum, in a process similar to female arousal. The spongy tissue fills with blood from arteries down the length of the penis. A little blood enters the corpus spongiosum; the remainder engorges the corpora cavernosa, which expand to hold 90% of the blood involved in an erection, increasing both in length and in diameter. The function of the corpus spongiosum is to prevent compression of the urethra during erection. Blood can leave the erectile tissue only through a drainage system of veins around the outside wall of the corpus cavernosum. The expanding spongy tissue presses against a surrounding dense tissue (tunica albuginea) constricting these veins, preventing blood from leaving. The penis becomes rigid as a result. The glans penis, the expanded cap of thecorpus spongiosum, remains more malleable during erection because its tunica albuginea is much thinner than elsewhere in the penis.

 


 


 

V.D.A. Distribution srl and the owner/editor of this site accept no responsibility as to the accuracy or otherwise of the information presented. By making use of the information contained in this site the reader assumes all risk that certain information may prove to be incorrect. All content in this website  is only for reference purposes and is not intended to substitute for advice given by a pharmacist, physician, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. This website is not lawfully accessible to persons under the age of 18. If you are under the age of 18 you must leave this site immediately. Penis-enhancement-secrets.com will not be liable for damages of any kind in way related to the website or the use of the information on the website. Please note that the site does not respond to any inquiry about medical conditions and it does not provide any medical advice. Medical advice must be obtained directly from a licensed health-care practitioner. The statements on this website (all pages included on domain AndroBath.com have not been evaluated by the Food and Drug Administration. These are solely the opinions of the owner/editor of this sito, and are provided for informational purposes only.

 

 

Bibliography
  • Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and psychosocial correlates: results of the Massachusetts male ageing study. J Urol 1994;151:54-61
  • OLeary M. Fowler F, Lenderking W et al. A brief male function inventory for urology. Urology 1995;46:697-705
  • Boolei M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel, effecive oral therapy for male erectile dysfunction. Br J Urol 1996;78:257-261
  • Goldstein I, Lue TF, Padma-Nathan H et al. for the Sildenafil Study Group. Oral sildenafil in the treat¬ment of erectile dysfunction. N Engl J Med 1998;20:1397-1404
  • Padma-Nathan H, Wayne JG, Hellstrom MD et al for the Medicated Urethral System for Erection (MUSE) Study Group.Treatment of men with erec¬tile dysfunction with transurethral alprostadil. N Engl J Med 1997;336:1-7
  • Williams G, Abbou C-C, Amar ET et al On behalf of the MUSE Study Group. Efficacy and safety of transurethral alprostadil therapy in men with erec¬tile dysfunction. Br J Urol 1998;81 :889-894
  • Linet OI, Ogring FG. Efficacy and safety of intra¬cavernosai alprostadil in men with erectile dy¬sfunction. N Engl J Med 1996;334:873-877
  • Porst H. The rationale for prostaglandin E1 in erec¬tile failure: a survey of worldwide experience. J Urol 1996;155:802-815
  • Robert Otto Becker, MD 1923 - 2008
  • Dening. S., (1992), The Mythology of Sex, Macmillan, New York
  • Friedman, D. M., (2007), Storia del Pene, Castelvecchi, Roma
  • Pisani E, Austoni E. Terapia medica e chirurgica radicale della Malattia di La Peyronie. Masson Ed., Milano, 1989